by EmpathiCSubstanceS | Dec 26, 2018 | Depression
The subgranular zone (SGZ) of dentate gyrus (DG) is one of the few regions in which neurogenesis is maintained throughout adulthood. It is believed that newborn neurons in this region encode temporal information about partially overlapping contextual memories. The...
by EmpathiCSubstanceS | Dec 26, 2018 | Kambo
If phase III clinical trials are successful, researchers suggest categorizing the drug as schedule IV In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, researchers suggest that if it clears phase III clinical trials, psilocybin...
by EmpathiCSubstanceS | Dec 26, 2018 | Anxiety
Researchers at Johns Hopkins University have suggested that psilocybin, which is found in hallucinogenic mushrooms, be reclassified from a Schedule I drug, with no known medical benefit, to a Schedule IV drug, which is akin to prescription sleeping pills....
by EmpathiCSubstanceS | Dec 26, 2018 | Anxiety
Researchers report LSD triggers a reduction in functional connection between areas of the brain that govern cognitive processes, while increasing connectivity in brain networks associated with sensory functions. Psychedelic drugs such as LSD have a profound impact on...
by EmpathiCSubstanceS | Dec 26, 2018 | Depression
Preliminary study suggests that ‘microdoses’ of psychedelics may enhance a person’s creative problem solving abilities The use of minute doses of magic mushrooms and truffles containing psychedelic substances could induce a state of unconstrained...
